pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
IMDELLTRA · news · pharmadog
← back to IMDELLTRA
News mentioning IMDELLTRA
18
stories
15d
Amgen starts MariTide autoinjector study as pivotal readouts approach
biospace
20d
Molecular Partners to lay off up to 44% of workforce in radiotherapy pivot
fiercebiotech
23d
A possible treatment for brain-eating amoebas, found in the sea
stat
24d
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data
biopharma dive
24d
ESMO 2026: Amgen’s Imdelltra slashes death risk by nearly 60% in small cell lung cancer
biospace
26d
STAT+: The ESMO presentation everyone’s been waiting for
stat
26d
#ESMO26: Amgen's Imdelltra regimen more than halves risk of death in Phase 3 lung cancer trial
endpoints
27d
Roche taps Zymeworks in up to $813M deal for preclinical T cell engager
endpoints
27d
Roche pays Zymeworks $55M for trispecific challenger to Amgen’s Imdelltra
fiercebiotech
28d
ESMO: Boehringer builds case for late-phase rival to Amgen’s Imdelltra
fiercebiotech
Sep 28, 26
Merck, Daiichi end plans to seek speedy approval of lung cancer ADC
biopharma dive
Sep 28, 26
Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal
fiercebiotech
Sep 24, 26
China’s Henlius carves out $440M T-cell engager deal with Amberstone
fiercebiotech
Sep 14, 26
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
fiercebiotech
Sep 11, 26
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharma dive
Sep 11, 26
GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
fiercebiotech
Sep 8, 26
Amgen’s T cell engager notches new major lung cancer victory
endpoints
Aug 27, 26
New data could widen use of AstraZeneca, Amgen immune disease drug
biopharma dive